Good Data Governance is Good Regulatory Compliance
Webinar | September 18, 2017
Mundipharma to discuss the importance of MDM to address IDMP, GDPR.
Semarchy, the Intelligent MDM™ company, announced today it will be co-hosting a webinar on Wednesday, 20 September 2017 featuring Mundipharma IT Services with Entity Group. Good Data Governance is Good Regulatory Compliance will focus on the crucial role Master Data Management (MDM) plays in compliance preparations for regulatory mandates such as ISO Protocols like IDMP, and broader regulations like GDPR.
About the Web Briefing
Gibson will discuss how the group leveraged xDM from Semarchy along with seasoned expertise from Entity Group. Together they put a structure in place to standardize, expedite, refine and improve all aspects of the data shared across Mundipharma. This included 100+ independent associated companies, operating across 100 countries, five production facilities and three research and development centers.
“As an organization that relies on partnerships in the way we do business, we appreciate the value of the relationships we have built while innovating our infrastructure—like those with Semarchy and Entity Group,” said Gibson. “Sharing some of the best practices we have around preparing for IDMP with collaborative data governance, which may be instructive as our fellow European organizations prepare for other regulations like GDPR, is a way of giving back to the broader community,” he added.
Entity Group, specialists in Enterprise Information Management, were included for the third year in a row in the Gartner 2017 Market Guide for External MDM Service Providers*. They make it their business to understand IDMP and other data-related regulations and have a portfolio of advisory assets covering all aspects of data governance and management. They shared the knowledge of addressing the gap between the data organizations have and the information they need in the recently-released book ‘Crossing the Data Delta.’
Healthcare, Life Sciences
The supply chain team of this international network of pharmaceutical companies needed better data to improve their efficiency while the finance team wanted a view of products and regulatory entities across markets to ensure compliance.